Paradigm Capital discloses 4.42% Integra LifeSciences (IART) stake with sole voting control
Rhea-AI Filing Summary
Integra LifeSciences Holdings Corp’s common stock has a reported significant shareholder, Paradigm Capital Management, Inc., as updated in an amended ownership report. Paradigm Capital Management, a New York S corporation based in Albany, reports beneficial ownership of 3,439,098 shares of Integra LifeSciences common stock.
This position represents 4.42% of the outstanding common stock of Integra LifeSciences. Paradigm Capital Management reports sole power to vote and dispose of all 3,439,098 shares, with no shared voting or dispositive power. The filing characterizes the holding as ownership of 5 percent or less of the class, reflecting its current status relative to regulatory reporting thresholds.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
sole power to vote financial
sole power to dispose financial
Ownership of 5 percent or less of a class regulatory
FAQ
What type of entity is Paradigm Capital Management in relation to its Integra LifeSciences (IART) holdings?
How does the filing describe Paradigm Capital Management’s ownership level in Integra LifeSciences (IART)?
AI-generated analysis. How Rhea-AI works. Not financial advice.